Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

OmniAb, Inc. (OABI) Cash Flow Statement

OmniAb, Inc. (OABI) generated -$17.7M of operating cash flow over the twelve months to 2026-06-30, spent $468000 on capital expenditure and had free cash flow of -$18.1M, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OABIOmniAb, Inc.Follow OABI — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
677.5M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
30 Oct, in 5 days
LineFY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Operating cash flow-3.62.3-39.7-36.5-17.7
Capital expenditure17.21.61.90.6-0.5
Free cash flow-20.80.7-41.5-37.0-18.1
Stock-based compensation18.324.821.515.8—

USD millions · SEC XBRL

OmniAb, Inc. — questions

What is OmniAb, Inc.'s operating cash flow?
-$17.7M over the twelve months to 2026-06-30.
How much does OmniAb, Inc. spend on capital expenditure?
$468000 over the twelve months to 2026-06-30.
What is OmniAb, Inc.'s free cash flow?
-$18.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.

Every figure on this page comes from OmniAb, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.